Pet Anthelmintic Drugs Market Key Players Analysis 2031
MARKET INTRODUCTION
Anthelmintics are drugs that are used to treat infections with parasitic worms. This includes both flat worms, e.g., flukes and tapeworms and round worms, i.e., nematodes. They are of huge importance for veterinary medicine.
MARKET DYNAMICS
The pet anthelmintic drugs market is driving due to the increasing prevalence of rise in prevalence of helminth infections caused by roundworm, hookworm, whipworm, and others worms. However, rise in drug resistance to most commonly prescribed anthelmintic drugs may impede the market growth in the review period.
MARKET SCOPE
The "Pet Anthelmintic Drugs Market Analysis to 2031" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of pet anthelmintic drugs market with detailed market segmentation by target pathogen, and distribution channel. The pet anthelmintic drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in pet anthelmintic drugs market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The pet anthelmintic drugs market is segmented on the basis of target pathogen, and distribution channel. On the basis of target pathogen, the market is categorized as ascaris lumbricoides [roundworm], trichuris trichiura [whipworm], enterobius vermicularis [pinworm], ancylostoma duodenale [hookworm], and others. On the basis of distribution channel, the market is categorized as veterinary pharmacies, and veterinary hospitals and clinics.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the pet anthelmintic drugs market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pet anthelmintic drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting pet anthelmintic drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the pet anthelmintic drugs market in these regions.
By Target Pathogen
By Distribution Channel
MARKET PLAYERS
The report covers key developments in the pet anthelmintic drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from pet anthelmintic drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for pet anthelmintic drugs in the global market. Below mentioned is the list of few companies engaged in the pet anthelmintic drugs market.
The report also includes the profiles of key players in pet anthelmintic drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Anthelmintics are drugs that are used to treat infections with parasitic worms. This includes both flat worms, e.g., flukes and tapeworms and round worms, i.e., nematodes. They are of huge importance for veterinary medicine.
MARKET DYNAMICS
The pet anthelmintic drugs market is driving due to the increasing prevalence of rise in prevalence of helminth infections caused by roundworm, hookworm, whipworm, and others worms. However, rise in drug resistance to most commonly prescribed anthelmintic drugs may impede the market growth in the review period.
MARKET SCOPE
The "Pet Anthelmintic Drugs Market Analysis to 2031" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of pet anthelmintic drugs market with detailed market segmentation by target pathogen, and distribution channel. The pet anthelmintic drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in pet anthelmintic drugs market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The pet anthelmintic drugs market is segmented on the basis of target pathogen, and distribution channel. On the basis of target pathogen, the market is categorized as ascaris lumbricoides [roundworm], trichuris trichiura [whipworm], enterobius vermicularis [pinworm], ancylostoma duodenale [hookworm], and others. On the basis of distribution channel, the market is categorized as veterinary pharmacies, and veterinary hospitals and clinics.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the pet anthelmintic drugs market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pet anthelmintic drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting pet anthelmintic drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the pet anthelmintic drugs market in these regions.
Pet Anthelmintic Drugs Market Report Analysis
Pet Anthelmintic Drugs Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX Million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Novartis AG
- Cipla Inc
- Sun Pharmaceutical Industries Ltd
- Amneal Pharmaceuticals LLC Impax Laboratories Inc
- Zoetis Inc
- GlaxoSmithKline plc
- Bayer AG
- Merck Co Inc Intervet Inc
- Boehringer Ingelheim International GmbH
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
By Target Pathogen
- Ascaris Lumbricoides
- Trichuris Trichiura
- Enterobius Vermicularis
- Ancylostoma Duodenale
By Distribution Channel
- Veterinary Pharmacies
- Veterinary Hospitals and Clinics
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
The report covers key developments in the pet anthelmintic drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from pet anthelmintic drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for pet anthelmintic drugs in the global market. Below mentioned is the list of few companies engaged in the pet anthelmintic drugs market.
The report also includes the profiles of key players in pet anthelmintic drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Novartis AG
- Cipla Inc.
- Sun Pharmaceutical Industries Ltd
- Amneal Pharmaceuticals LLC. (Impax Laboratories, Inc.)
- Zoetis, Inc.
- GlaxoSmithKline plc
- Bayer AG
- Merck & Co., Inc. (Intervet Inc.)
- Boehringer Ingelheim International GmbH
- Virbac
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Pet Anthelmintic Drugs Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ XX Million |
| Market Size by 2031 | US$ XX Million |
| Global CAGR (2023 - 2031) | XX% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Target Pathogen
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1. Novartis AG
2. Cipla Inc.
3. Sun Pharmaceutical Industries Ltd
4. Amneal Pharmaceuticals LLC. (Impax Laboratories, Inc.)
5. Zoetis, Inc.
6. GlaxoSmithKline plc
7. Bayer AG
8. Merck & Co., Inc. (Intervet Inc.)
9. Boehringer Ingelheim International GmbH
10. Virbac
1. Novartis AG
2. Cipla Inc.
3. Sun Pharmaceutical Industries Ltd
4. Amneal Pharmaceuticals LLC. (Impax Laboratories, Inc.)
5. Zoetis, Inc.
6. GlaxoSmithKline plc
7. Bayer AG
8. Merck & Co., Inc. (Intervet Inc.)
9. Boehringer Ingelheim International GmbH
10. Virbac
Get Free Sample For